{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:54:33Z","timestamp":1762430073986},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,3,18]],"date-time":"2006-03-18T00:00:00Z","timestamp":1142640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s00405-006-0027-9","type":"journal-article","created":{"date-parts":[[2006,3,17]],"date-time":"2006-03-17T16:10:19Z","timestamp":1142611819000},"page":"622-626","source":"Crossref","is-referenced-by-count":26,"title":["TNF\u03b1 blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis"],"prefix":"10.1007","volume":"263","author":[{"given":"David","family":"Lobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Trinidad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Garc\u00eda-Berrocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mar\u00eda","family":"Verdaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ram\u00edrez-Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,18]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00003495-200565040-00004","volume":"65","author":"NJ Bansback","year":"2005","unstructured":"Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA (2005) An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists. Drugs 65:473\u2013496","journal-title":"Drugs"},{"key":"27_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2004.09.001","volume":"4","author":"C Botsios","year":"2005","unstructured":"Botsios C (2005) Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmun Rev 4:162\u2013170","journal-title":"Autoimmun Rev"},{"key":"27_CR3","first-page":"87","volume":"20","author":"GJ Carvalho","year":"1999","unstructured":"Carvalho GJ, Lalwani AK (1999) The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. Am J Otol 20:87\u201390","journal-title":"Am J Otol"},{"key":"27_CR4","first-page":"416","volume":"46","author":"JR Garc\u00eda-Berrocal","year":"1995","unstructured":"Garc\u00eda-Berrocal JR, Pinilla Urraca M, Ramirez-Camacho R, Gonz\u00e1lez Martin F, L\u00f3pez Cortijo C (1995) Patolog\u00eda de o\u00eddo interno de probable origen autoinmune y su respuesta al tratamiento esteroideo. Acta Otorrinolaring Esp 46:416\u2013420","journal-title":"Acta Otorrinolaring Esp"},{"key":"27_CR5","first-page":"5","volume":"48","author":"JR Garc\u00eda-Berrocal","year":"1997","unstructured":"Garc\u00eda-Berrocal JR, Vicente J, Arellano B, Gonz\u00e1lez FM, Ram\u00edrez-Camacho R (1997) Laberintitis experimental autoimmune: evaluaci\u00f3n de diversos modelos en cobayas. Acta Otorrinolaring Esp 48:5\u201310","journal-title":"Acta Otorrinolaring Esp"},{"key":"27_CR6","first-page":"557","volume":"51","author":"JR Garc\u00eda-Berrocal","year":"2000","unstructured":"Garc\u00eda-Berrocal JR, Ram\u00edrez-Camacho R, Zurita M, Arellano B (2000) Respuesta celular inmune precoz en la laberintitis experimental: Estudio inmunohistoqu\u00edmico. Acta Otorrinolaring Esp 51:557\u2013561","journal-title":"Acta Otorrinolaring Esp"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/000348940411300512","volume":"113","author":"JR Garc\u00eda-Berrocal","year":"2004","unstructured":"Garc\u00eda-Berrocal JR, Ram\u00edrez-Camacho R, Trinidad A, Zurita M, de la Fuente R, Lobo D (2004) Controversies and criticisms on designs for experimental autoimmune labyrinthitis. Ann Otol Rhinol Laryngol 113:404\u2013410","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"27_CR8","first-page":"99","volume":"4","author":"JR Garc\u00eda-Berrocal","year":"2004","unstructured":"Garc\u00eda-Berrocal JR, Ram\u00edrez-Camacho R, Trinidad A, Lobo D (2004) Glucocorticoids: the best therapy for immune-mediated inner ear disease. Curr Topics Steroid Res 4:99\u2013104","journal-title":"Curr Topics Steroid Res"},{"key":"27_CR9","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Berrocal JR, Trinidad A, Ram\u00edrez-Camacho R, Lobo D, Verdaguer JM, Ib\u00e1\u00f1ez A (2005) Immunologic work-up study for inner ear disorders: looking for a rational strategy. Acta Oto-Laryngol 125:814\u2013818","DOI":"10.1080\/00016480510038059"},{"key":"27_CR10","unstructured":"Garc\u00eda-Berrocal JR, Ram\u00edrez-Camacho R, Lobo D, Trinidad A, Verdaguer JM (2006) Adverse effects of glucocorticoids therapy for inner ear disorders. ORL (in press)"},{"key":"27_CR11","unstructured":"Goffe B (2004) Etanercept (Enbrel) \u2013 an update. Skin Therap Lett 9:1\u20134"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/000164801300366552","volume":"121","author":"MV Goycoolea","year":"2001","unstructured":"Goycoolea MV (2001) Clinical aspects of round window permeability under normal and pathological conditions. Acta Otolaryngol 121:437\u2013447","journal-title":"Acta Otolaryngol"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.290.14.1875","volume":"290","author":"JP Harris","year":"2003","unstructured":"Harris JP, Weisman MH, Derebery JM, Espeland MA, Gautz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko TK, Rauch SD, Telian SA, Brookhouser PE (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875\u20131883","journal-title":"JAMA"},{"key":"27_CR14","first-page":"1864","volume":"30","author":"D Kahna","year":"2003","unstructured":"Kahna D, Liebling MR, Louie JS (2003) Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30:1864\u20131867","journal-title":"J Rheumatol"},{"key":"27_CR15","unstructured":"Lobo D, Garc\u00eda-Berrocal JR, Trinidad A, San Rom\u00e1n J, Ram\u00edrez-Camacho R (2003) Local alternatives to systemic inner ear therapy. In: 3rd Int Symp Inner Ear Pharmacol. Malaga, Spain"},{"key":"27_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00005537-200003000-00024","volume":"110","author":"C Ma","year":"2000","unstructured":"Ma C, Billings P, Harris JP, Keithley EM (2000) Characterization of an experimentally induced inner ear immune response. Laryngoscope 110:451\u2013456","journal-title":"Laryngoscope"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.21179","volume":"53","author":"EL Matteson","year":"2005","unstructured":"Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU (2005) Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 53:337\u2013342","journal-title":"Arthritis Rheum"},{"key":"27_CR18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000348947908800501","volume":"88","author":"BF McCabe","year":"1979","unstructured":"McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585\u2013589","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00002281-200105000-00006","volume":"13","author":"MU Rahman","year":"2001","unstructured":"Rahman MU, Poe DS, Choi HK (2001) Autoimmune vestibulo-cochlear disorders. Curr Opin Rheumatol 13:184\u2013189","journal-title":"Curr Opin Rheumatol"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00129492-200109000-00010","volume":"22","author":"MU Rahman","year":"2001","unstructured":"Rahman MU, Poe DS, Choi HK (2001) Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol 22:619\u2013624","journal-title":"Otol Neurotol"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00005537-200209000-00019","volume":"112","author":"H Satoh","year":"2002","unstructured":"Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM (2002) Tumor necrosis factor-alpha, an initiator, an etanercept, an inhibitor of cochlear inflammation. Laryngoscope 112:1627\u20131634","journal-title":"Laryngoscope"},{"key":"27_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10162-002-3025-7","volume":"4","author":"H Satoh","year":"2003","unstructured":"Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM (2003) Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. JARO 4:139\u2013147","journal-title":"JARO"},{"key":"27_CR23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/000164802320396402","volume":"122","author":"H Staecker","year":"2002","unstructured":"Staecker H, Lefebvre PP (2002) Autoimmune sensorineural hearing loss improved by tumor necrosis factor \u03b1 blockade: a case report. Acta Otolaryngol 122:684\u2013687","journal-title":"Acta Otolaryngol"},{"key":"27_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","volume":"34","author":"RS Wallis","year":"2005","unstructured":"Wallis RS, Ehlers S (2005) Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 34:34\u201338","journal-title":"Semin Arthritis Rheum"},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00129492-200301000-00012","volume":"24","author":"X Wang","year":"2003","unstructured":"Wang X, Truong T, Billings PB, Harris JP, Keithley FM (2003) Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol 24:52\u201357","journal-title":"Otol Neurotol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-006-0027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-006-0027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-006-0027-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:00:36Z","timestamp":1559066436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-006-0027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,18]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s00405-006-0027-9","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,18]]}}}